Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage.
about
Neuroprotection in GlaucomaNovel therapies for open-angle glaucomaOral microbiome link to neurodegeneration in glaucomaModeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressureInducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer.Inducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive ratsDifferential gene expression in glaucomaGlaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancementRegulation of nitric oxide production by δ-opioid receptors during glaucomatous injury.Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucomaGlobal changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model.Solving the lost in translation problem: improving the effectiveness of translational research.Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma.Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.Friend or foe? Resolving the impact of glial responses in glaucomaReliability and sensitivity of the TonoLab rebound tonometer in awake Brown Norway ratsMechanisms of retinal ganglion cell injury and defense in glaucoma.Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma.Autocrine and paracrine interactions and neuroprotection in glaucoma.Challenges in the development of glaucoma neuroprotection therapy.Glaucoma: recent advances in the involvement of autoimmunity.Effect of erythropoietin on the expression of HIF-1 and iNOS in retina in chronic ocular hypertension rats.Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model.Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?Delta Opioids: Neuroprotective Roles in Preclinical Studies.Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course.Functional and Structural Evaluation of Sildenafil in a Rat Model of Acute Retinal Ischemia/Reperfusion Injury.
P2860
Q26740388-BB17431C-3E2A-4E15-B3B2-E9A68945768FQ26851132-3EC5DB4B-0281-438C-B439-C8BBFC5D11E4Q27316016-4DA5DD35-2066-4435-AFA9-EEFA4FC404ECQ30671362-D84535B9-25CC-4D49-9A5A-09331E1F2C3AQ33311386-B75D941B-AA62-4774-9A51-C35E605481E8Q33523671-F7722345-986B-4313-B9F1-2753EA7858A1Q33789800-F62D59C9-85BF-4154-A40D-B20699AB7704Q33790678-3DF9D405-2F79-412A-B370-1CCB998E003AQ34255732-A981754A-80C3-43F5-9068-1DAB40D70EE1Q34362259-8B3BA1A5-DF4F-4CE7-9F4A-AF3B1FD70C6CQ34755301-9CCF842B-1D35-4560-BF42-53507670EEAFQ35945481-FA4511FB-00EA-4D76-B45B-8108F55119E9Q36487221-053AE52F-F541-43B9-9A73-D94C47D5681AQ36833382-9A787529-BF1E-45AD-B0E0-17CAC7634592Q36944788-95ADFC58-FF3A-4049-9670-E961DDE569F7Q37230041-7C9407E3-10F8-4EE9-A7A1-0CDCDC6C5B2AQ37352499-59A4492D-6648-4B01-B1CF-4C77F3D5D306Q37731595-1DF6A07F-9F99-47C2-9114-27D9F2D02C86Q37779827-C585CCA2-2EC7-43FF-B596-899858346EE9Q38077464-CB8421C3-24BE-4A6D-B455-B92AB4BF2A92Q38087849-F1912F8C-0E13-4C9C-B08E-BB20045A668AQ38913448-2F0004E6-0F86-4D09-B380-7BA6398127B0Q41960788-BCABFCBE-AD69-4862-B079-73FA2CE6F664Q41980222-A4896500-666D-45E5-9B68-EF67CE3D732AQ42671324-ECAF7022-FBB4-4DF2-AB09-C20D0CA7334EQ49925827-6302CF08-1934-40F1-8715-01FACC3BD846Q50705613-CA6597BE-CA36-459D-9E70-745700EB6FD8Q51639287-B0589EDC-61C1-4C29-A3AB-6A93580B51AC
P2860
Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Evaluation of inducible nitric ...... re-induced optic nerve damage.
@en
Evaluation of inducible nitric ...... re-induced optic nerve damage.
@nl
type
label
Evaluation of inducible nitric ...... re-induced optic nerve damage.
@en
Evaluation of inducible nitric ...... re-induced optic nerve damage.
@nl
prefLabel
Evaluation of inducible nitric ...... re-induced optic nerve damage.
@en
Evaluation of inducible nitric ...... re-induced optic nerve damage.
@nl
P2093
P356
P1476
Evaluation of inducible nitric ...... re-induced optic nerve damage.
@en
P2093
Abbot F Clark
Allan R Shepard
Elaine C Johnson
Iok-Hou Pang
John C Morrison
Mark R Hellberg
William O Cepurna
P304
P356
10.1167/IOVS.04-0829
P407
P577
2005-04-01T00:00:00Z